Anne-Laure Marcerou focuses her practice on mergers and acquisitions and pharmaceutical law.
Ms. Marcerou assists U.S. and European major pharmaceutical and medical devices companies, as well as healthcare and biotech firms with respect to French and European pharmaceutical and regulatory issues. This includes:
- Clinical trials
- Promotional and advertising activities
- Pricing and reimbursement issues
- Marketing authorizations
- Data protection
- Contract manufacturing
Significant Representations
- The shareholders of a French biotechnology company in the sale of 100% of the shares of the company to a French pharmaceutical company
- A Dutch company, international supplier of medical devices and pharmaceuticals, in connection with the EUR 17 million acquisition of a French family owned-group, supplier of a broad range of medical devices to healthcare professionals
- A major pharmaceutical company in its acquisition of one of the leading pharmaceutical groups in Algeria specialized in the manufacturing and distribution of medicinal products
- An international pharmaceutical company in its acquisition of a French contract manufacturer, which used to manufacture products as a sub-contractor for a number of years
- A U.S. pharmaceutical company in its €170 million acquisition of a French medical device manufacturer
- The shareholder of the fourth largest independent French pharmaceutical company for its sale to an Indian investor
- A pharmaceutical contract manufacturer in its sale to a French investment fund
- A major U.S. biopharma in connection with the creation of a biotech dedicated investment fund
Education
Université Paris - Sud 11, DEA, 1997
ESSEC Business School, Droit des Affaires Internationales et Management, 1997
Bar Admissions/Qualifications
Paris
Languages
French
English